C - Chemistry – Metallurgy – 12 – P
Patent
C - Chemistry, Metallurgy
12
P
C12P 21/00 (2006.01) A61K 38/28 (2006.01) C07K 14/62 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2049961
2049961 9011299 PCTABS00002 Novel insulin compounds having a desirably protracted insulin action and/or antigenicity are provided. The novel insulin compounds are represented by formula (II), wherein E individually represents Glu or a neutral amino acid residue which can be coded for by nucleotide sequences, N represents an amino acid residue which can be coded for by nucleotide sequences, T represents Thr or Arg, X represents Thr, Ser, Ala or OH, and Y represents OR or NR1R2, where R, R1 and R2 individually represents hydrogen or lower alkyl, but is not present when X represents OH.
Balschmidt Per
Hansen Finn Benned
Mccarthy Tetrault Llp
Novo Nordisk A/s
LandOfFree
Insulin compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Insulin compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Insulin compounds will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1690880